Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
GSK Gears Up for Q3 Earnings: Will It Surpass Estimates?
09:01am, Tuesday, 24'th Oct 2023
We expect GSK's specialty products like Cabenuva, Juluca, Dovato, Bexsero, Trelegy Ellipta and Shingrix to drive third-quarter sales performance.
Barclays and AstraZeneca up staff pay as Real Living Wage increases
08:18am, Tuesday, 24'th Oct 2023
Employers which pay staff the Real Living Wage (RLW) will have to find an extra 10% after it was increased to £12 in the UK and £13.10 in London on Tuesday. Providing workers with a salary that is i
AstraZeneca said U.S. FDA has accepted for review its Flumist self-administered flu vaccine
07:21am, Tuesday, 24'th Oct 2023
AstraZeneca PLC AZN, -1.22% AZN, +1.45% said Tuesday the U.S. Food and Drug Administration has accepted its application for approval of a self-administered flu vaccine. The company said the regulator
AstraZeneca CEO: Objective is to replace chemotherapy
06:01am, Tuesday, 24'th Oct 2023
Pascal Soriot, CEO of AstraZeneca, discusses the progress the company is making with cancer drugs.
US FDA accepts AstraZeneca's self-administered flu vaccine for review
02:11am, Tuesday, 24'th Oct 2023
AstraZeneca said on Tuesday the U.S. Food and Drug Administration (FDA) has accepted for review the company's application seeking approval for patients or caregivers to administer its nasal flu vaccin
AstraZeneca boss Pascal Soriot dismisses exit talk
10:01am, Monday, 23'rd Oct 2023
AstraZeneca PLC (LSE:AZN) boss Pascal Soriot has told Bloomberg that reports of his imminent departure from the drugmaker are “fake news.” Soriot, speaking at the European Society for Medical Onc
AstraZeneca gains European approval for lung cancer drug
02:57am, Monday, 23'rd Oct 2023
AstraZeneca PLC (LSE:AZN) has announced that its jointly developed lung cancer drug has been approved for use in the European Union. Enhertu, which has been co-developed with Daiichi Sankyo, received
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
11:18am, Friday, 20'th Oct 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know
07:34pm, Thursday, 19'th Oct 2023
The latest trading day saw Astrazeneca (AZN) settling at $64.42, representing a -1.26% change from its previous close.
AstraZeneca PLC (AZN) is Attracting Investor Attention: Here is What You Should Know
10:32am, Wednesday, 18'th Oct 2023
Zacks.com users have recently been watching Astrazeneca (AZN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AstraZeneca shares fall as abstract for lung cancer trial data disappoints
08:26am, Wednesday, 18'th Oct 2023
Shares in AstraZeneca fell more than 4% on Wednesday after the publication of an abstract on its experimental precision drug's use in lung cancer in a late-stage trial disappointed some analysts.
AstraZeneca leads FTSE fallers with no obvious reason
07:19am, Wednesday, 18'th Oct 2023
AstraZeneca PLC (LSE:AZN) shares were the biggest faller on the FTSE 100 on Wednesday, down 3.6%, with no obvious reason for the sell-off. News and broker comments on the Anglo-Swedish drug giant s
AstraZeneca's (AZN) Tagrisso Combo Gets FDA's Priority Review
12:46pm, Tuesday, 17'th Oct 2023
The FDA accepts and grants priority review to AstraZeneca's (AZN) sNDA, seeking approval of Tagrisso combined with chemotherapy as a first-line treatment for EGFR-mutated advanced NSCLC. A decision is
AstraZeneca's Tagrisso-chemo combo given priority review in US
02:34am, Monday, 16'th Oct 2023
The combination of AstraZeneca's cancer drug, Tagrisso, with chemotherapy has been been accepted and granted priority review by the U.S. Food and Drug Administration (FDA), the British drugmaker said
Why the Market Dipped But (AZN) Gained Today
07:32pm, Thursday, 12'th Oct 2023
Astrazeneca (AZN) concluded the recent trading session at $68.11, signifying a +0.15% move from its prior day's close.
